Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
56.01
+0.02 (0.04%)
Dec 5, 2025, 4:00 PM EST - Market closed
Utah Medical Products Revenue
Utah Medical Products had revenue of $9.81M in the quarter ending September 30, 2025, a decrease of -1.93%. This brings the company's revenue in the last twelve months to $38.63M, down -12.35% year-over-year. In the year 2024, Utah Medical Products had annual revenue of $40.92M, down -18.56%.
Revenue (ttm)
$38.63M
Revenue Growth
-12.35%
P/S Ratio
4.77
Revenue / Employee
$231,335
Employees
167
Market Cap
179.44M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 40.92M | -9.33M | -18.56% |
| Dec 31, 2023 | 50.24M | -2.06M | -3.93% |
| Dec 31, 2022 | 52.30M | 3.23M | 6.59% |
| Dec 31, 2021 | 49.07M | 6.87M | 16.28% |
| Dec 31, 2020 | 42.20M | -4.71M | -10.04% |
| Dec 31, 2019 | 46.91M | 4.84M | 11.49% |
| Dec 31, 2018 | 42.07M | 574.00K | 1.38% |
| Dec 31, 2017 | 41.50M | 2.11M | 5.36% |
| Dec 31, 2016 | 39.39M | -861.00K | -2.14% |
| Dec 31, 2015 | 40.25M | -1.13M | -2.72% |
| Dec 31, 2014 | 41.38M | 794.00K | 1.96% |
| Dec 31, 2013 | 40.58M | -1.06M | -2.54% |
| Dec 31, 2012 | 41.64M | 3.71M | 9.78% |
| Dec 31, 2011 | 37.93M | 12.81M | 50.99% |
| Dec 31, 2010 | 25.12M | -795.00K | -3.07% |
| Dec 31, 2009 | 25.92M | -2.32M | -8.20% |
| Dec 31, 2008 | 28.23M | -720.00K | -2.49% |
| Dec 31, 2007 | 28.95M | -251.00K | -0.86% |
| Dec 31, 2006 | 29.20M | 1.06M | 3.77% |
| Dec 31, 2005 | 28.14M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
UTMD News
- 4 weeks ago - Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend - Accesswire
- 6 weeks ago - UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2025 - Accesswire
- 4 months ago - Utah Medical Products, Inc. Announces Quarterly Dividend - Accesswire
- 4 months ago - Utah Medical Products Reports Q2 Decline - The Motley Fool
- 4 months ago - UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2025 - Accesswire
- 5 months ago - Utah Medical Products: Deep Discount Is Drawing One Legendary Investor's Interest - Seeking Alpha
- 7 months ago - Stock Picks From Seeking Alpha's April 2025 New Analysts - Seeking Alpha
- 7 months ago - Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025 - Accesswire